Mesenchymal stem cells-derived therapies for subarachnoid hemorrhage in preclinical rodent models: a meta-analysis

BACKGROUND: Mesenchymal stem cells (MSCs) and MSCs-derived extracellular vesicles (EVs) have emerged as potential novel therapies for subarachnoid hemorrhage (SAH). However, their effects remain incompletely understood. We aim to comprehensively evaluate the effect of MSCs-derived therapies in roden...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jialin, Liu, Jianyang, Huang, Yan, Lan, Ziwei, Tang, Xiangqi, Hu, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800223/
https://www.ncbi.nlm.nih.gov/pubmed/35093176
http://dx.doi.org/10.1186/s13287-022-02725-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800223/
https://www.ncbi.nlm.nih.gov/pubmed/35093176
http://dx.doi.org/10.1186/s13287-022-02725-2

Ejemplares similares